Fig. 9

Schematic diagram. ALKBH5-mediated m6A demethylation modification induces FOXP2 degradation and blocks FOXP2-mediated CEP55 transcriptional repression, thereby promoting cell cycle and epithelial-mesenchymal transition, leading to the malignant progression of ovarian cancer